Evidence map›Paper›PMID 37892197›Full record

ReviewBiomolecules2023

Iturin: A Promising Cyclic Lipopeptide with Diverse Applications.

Deepak A Yaraguppi, Zabin K Bagewadi, Ninganagouda R Patil, Nitin Mantri

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
27.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Biotechnological Potential of RhizosphericInternational journal of molecular sciences · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Bioprotective Strategies to ControlInternational journal of molecular sciences · 2025
    Review
  15. Article
  16. Antagonistic mechanism ofApplied and environmental microbiology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Deepak A YaraguppiDepartment of Biotechnology, KLE Technological University, Hubballi 580031, Karnataka, India.ORCID 0000-0002-2371-7739
Zabin K BagewadiDepartment of Biotechnology, KLE Technological University, Hubballi 580031, Karnataka, India.ORCID 0000-0002-6650-7045
Ninganagouda R PatilDepartment of Physics, B. V Bhoomaraddi College of Engineering and Technology, Hubballi 580031, Karnataka, India.ORCID 0000-0002-7519-1142
Nitin MantriThe Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia.ORCID 0000-0002-7621-035X
KLE Technological University · INThe University of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This comprehensive review examines iturin, a cyclic lipopeptide originating from

Indexed as

Antifungal AgentsBacillus subtilisAnti-Bacterial AgentsAntiviral AgentsLipopeptidesAnti-Bacterial AgentsAntifungal AgentsAntiviral AgentsLipopeptidesapplicationsbiological activityin silico studiesiturinproduction

Identifiers

PMID37892197
PMCPMC10604914
OpenAlexW4387570919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.